Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition

D. C. Frankenfield, H. N. Reynolds, M. M. Badellino, Ch E. Wiles

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Objective: To determine glucose balance during dextrose-free continuous hemodiafiltration with or without dextrose-containing ultrafiltrate replacement fluid and full nutritional support. Design: Prospective, nonrandomized, observational study. Setting: A 24-bed multiple trauma critical care unit in a level-I trauma center. Patients: Seventeen multiple trauma patients with multiple organ dysfunction syndrome requiring hemodialysis for acute renal failure. Interventions: Continuous hemodiafiltration effluent volume and glucose concentration were measured. Study days were classified according to whether dextrose was used in the ultrafiltrate replacement therapy. Use of dextrose in replacement therapy was determined clinically. Parenteral nutrition was not altered for potential glucose absorption from continuous hemodiafiltration. Ultrafiltrate replacement consisted of 5% dextrose in saline on 21 study days (D5YES) and dextrose-free solutions on 54 study days (D5NO). Results: The D5YES group received 316±145 g glucose/day from the ultrafiltrate replacement fluid, in addition to glucose in total parenteral nutrition (total glucose intake=942±229 g/day in D5YES, 682±154 g/day in D5NO) (p<0.05). Glucose loss in continuous hemodiafiltration effluent was 82±61 g/day in D5YES and 57±22 g/day in D5NO (P<0.05), for a net glucose uptake of 8.1±2.1 mg/kg per min in D5YES and 5.4±1.5 mg/kg per min in D5NO (p<0.05). Glucose loss was predictable when dialysate and ultrafiltrate replacement fluids were dextrose-free (R2=0.77), but less so when dextrose was used as ultrafiltrate replacement (R2=0.47). Conclusion: Dextrose-free dialysate promotes glucose loss during continuous hemodiafiltration, but the loss is small and predictable. Use of a dextrose-containing ultrafiltrate replacement fluid results in a significant increase in glucose intake without a commensurate increase in glucose loss, and makes glucose loss in effluent less predictable.

Original languageEnglish (US)
Pages (from-to)1016-1022
Number of pages7
JournalIntensive Care Medicine
Volume21
Issue number12
DOIs
StatePublished - Dec 1 1995

Fingerprint

Hemodiafiltration
Total Parenteral Nutrition
Glucose
Multiple Trauma
Dialysis Solutions

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cite this

Frankenfield, D. C. ; Reynolds, H. N. ; Badellino, M. M. ; Wiles, Ch E. / Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. In: Intensive Care Medicine. 1995 ; Vol. 21, No. 12. pp. 1016-1022.
@article{6f2da39df9704880bdead2e7940cfea2,
title = "Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition",
abstract = "Objective: To determine glucose balance during dextrose-free continuous hemodiafiltration with or without dextrose-containing ultrafiltrate replacement fluid and full nutritional support. Design: Prospective, nonrandomized, observational study. Setting: A 24-bed multiple trauma critical care unit in a level-I trauma center. Patients: Seventeen multiple trauma patients with multiple organ dysfunction syndrome requiring hemodialysis for acute renal failure. Interventions: Continuous hemodiafiltration effluent volume and glucose concentration were measured. Study days were classified according to whether dextrose was used in the ultrafiltrate replacement therapy. Use of dextrose in replacement therapy was determined clinically. Parenteral nutrition was not altered for potential glucose absorption from continuous hemodiafiltration. Ultrafiltrate replacement consisted of 5{\%} dextrose in saline on 21 study days (D5YES) and dextrose-free solutions on 54 study days (D5NO). Results: The D5YES group received 316±145 g glucose/day from the ultrafiltrate replacement fluid, in addition to glucose in total parenteral nutrition (total glucose intake=942±229 g/day in D5YES, 682±154 g/day in D5NO) (p<0.05). Glucose loss in continuous hemodiafiltration effluent was 82±61 g/day in D5YES and 57±22 g/day in D5NO (P<0.05), for a net glucose uptake of 8.1±2.1 mg/kg per min in D5YES and 5.4±1.5 mg/kg per min in D5NO (p<0.05). Glucose loss was predictable when dialysate and ultrafiltrate replacement fluids were dextrose-free (R2=0.77), but less so when dextrose was used as ultrafiltrate replacement (R2=0.47). Conclusion: Dextrose-free dialysate promotes glucose loss during continuous hemodiafiltration, but the loss is small and predictable. Use of a dextrose-containing ultrafiltrate replacement fluid results in a significant increase in glucose intake without a commensurate increase in glucose loss, and makes glucose loss in effluent less predictable.",
author = "Frankenfield, {D. C.} and Reynolds, {H. N.} and Badellino, {M. M.} and Wiles, {Ch E.}",
year = "1995",
month = "12",
day = "1",
doi = "10.1007/BF01700664",
language = "English (US)",
volume = "21",
pages = "1016--1022",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "12",

}

Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. / Frankenfield, D. C.; Reynolds, H. N.; Badellino, M. M.; Wiles, Ch E.

In: Intensive Care Medicine, Vol. 21, No. 12, 01.12.1995, p. 1016-1022.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition

AU - Frankenfield, D. C.

AU - Reynolds, H. N.

AU - Badellino, M. M.

AU - Wiles, Ch E.

PY - 1995/12/1

Y1 - 1995/12/1

N2 - Objective: To determine glucose balance during dextrose-free continuous hemodiafiltration with or without dextrose-containing ultrafiltrate replacement fluid and full nutritional support. Design: Prospective, nonrandomized, observational study. Setting: A 24-bed multiple trauma critical care unit in a level-I trauma center. Patients: Seventeen multiple trauma patients with multiple organ dysfunction syndrome requiring hemodialysis for acute renal failure. Interventions: Continuous hemodiafiltration effluent volume and glucose concentration were measured. Study days were classified according to whether dextrose was used in the ultrafiltrate replacement therapy. Use of dextrose in replacement therapy was determined clinically. Parenteral nutrition was not altered for potential glucose absorption from continuous hemodiafiltration. Ultrafiltrate replacement consisted of 5% dextrose in saline on 21 study days (D5YES) and dextrose-free solutions on 54 study days (D5NO). Results: The D5YES group received 316±145 g glucose/day from the ultrafiltrate replacement fluid, in addition to glucose in total parenteral nutrition (total glucose intake=942±229 g/day in D5YES, 682±154 g/day in D5NO) (p<0.05). Glucose loss in continuous hemodiafiltration effluent was 82±61 g/day in D5YES and 57±22 g/day in D5NO (P<0.05), for a net glucose uptake of 8.1±2.1 mg/kg per min in D5YES and 5.4±1.5 mg/kg per min in D5NO (p<0.05). Glucose loss was predictable when dialysate and ultrafiltrate replacement fluids were dextrose-free (R2=0.77), but less so when dextrose was used as ultrafiltrate replacement (R2=0.47). Conclusion: Dextrose-free dialysate promotes glucose loss during continuous hemodiafiltration, but the loss is small and predictable. Use of a dextrose-containing ultrafiltrate replacement fluid results in a significant increase in glucose intake without a commensurate increase in glucose loss, and makes glucose loss in effluent less predictable.

AB - Objective: To determine glucose balance during dextrose-free continuous hemodiafiltration with or without dextrose-containing ultrafiltrate replacement fluid and full nutritional support. Design: Prospective, nonrandomized, observational study. Setting: A 24-bed multiple trauma critical care unit in a level-I trauma center. Patients: Seventeen multiple trauma patients with multiple organ dysfunction syndrome requiring hemodialysis for acute renal failure. Interventions: Continuous hemodiafiltration effluent volume and glucose concentration were measured. Study days were classified according to whether dextrose was used in the ultrafiltrate replacement therapy. Use of dextrose in replacement therapy was determined clinically. Parenteral nutrition was not altered for potential glucose absorption from continuous hemodiafiltration. Ultrafiltrate replacement consisted of 5% dextrose in saline on 21 study days (D5YES) and dextrose-free solutions on 54 study days (D5NO). Results: The D5YES group received 316±145 g glucose/day from the ultrafiltrate replacement fluid, in addition to glucose in total parenteral nutrition (total glucose intake=942±229 g/day in D5YES, 682±154 g/day in D5NO) (p<0.05). Glucose loss in continuous hemodiafiltration effluent was 82±61 g/day in D5YES and 57±22 g/day in D5NO (P<0.05), for a net glucose uptake of 8.1±2.1 mg/kg per min in D5YES and 5.4±1.5 mg/kg per min in D5NO (p<0.05). Glucose loss was predictable when dialysate and ultrafiltrate replacement fluids were dextrose-free (R2=0.77), but less so when dextrose was used as ultrafiltrate replacement (R2=0.47). Conclusion: Dextrose-free dialysate promotes glucose loss during continuous hemodiafiltration, but the loss is small and predictable. Use of a dextrose-containing ultrafiltrate replacement fluid results in a significant increase in glucose intake without a commensurate increase in glucose loss, and makes glucose loss in effluent less predictable.

UR - http://www.scopus.com/inward/record.url?scp=0029591117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029591117&partnerID=8YFLogxK

U2 - 10.1007/BF01700664

DO - 10.1007/BF01700664

M3 - Article

C2 - 8750127

AN - SCOPUS:0029591117

VL - 21

SP - 1016

EP - 1022

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 12

ER -